Avathon Launches AI-Powered Classification for Global Trade Management
Livingston International partners with Avathon to drive AI-powered classification, creating a new standard for speed, quality, and confidence in global trade management... Read more.
Avathon Launches AI-Powered Classification for Global Trade Management
Livingston International partners with Avathon to drive AI-powered classification, creating a new standard for speed, quality, and confidence in global trade management... Read more.
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD),... Read more.
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD),... Read more.
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,... Read more.
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,... Read more.
Chartis Research and Metrika Release Comprehensive Framework for Managing Digital Asset Risk
New Report Introduces ‘Integrated Composability Risk’ (ICR) – A Novel Risk Category for Digital Assets and Blockchains NEW YORK, Oct. 9, 2025 /PRNewswire/... Read more.
Chartis Research and Metrika Release Comprehensive Framework for Managing Digital Asset Risk
New Report Introduces ‘Integrated Composability Risk’ (ICR) – A Novel Risk Category for Digital Assets and Blockchains NEW YORK, Oct. 9, 2025 /PRNewswire/... Read more.
Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
ADCE-D01 is a first-in-class antibody-drug conjugate targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple soft... Read more.
Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
ADCE-D01 is a first-in-class antibody-drug conjugate targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple soft... Read more.